Figure - PMC

Skip to main content

An official website of the United States government

Here's how you know

Here's how you know

Official websites use .gov
A .gov website belongs to an official government organization in the United States.

Secure .gov websites use HTTPS
A lock ( ) or https:// means you've safely connected to the .gov website. Share sensitive information only on official, secure websites.

View full-text article in PMC

. 2015 Aug 14;10(4):2107–2117. doi: 10.3892/ol.2015.3609

Search in PMC
Search in PubMed
View in NLM Catalog
Add to search

Copyright: © Li et al. This is an open access article distributed under the terms of a Creative Commons Attribution License.

This is an open-access article licensed under a Creative Commons Attribution-NonCommercial 4.0 Unported License. The article may be redistributed, reproduced, and reused for non-commercial purposes, provided the original source is properly cited.

PMC Copyright notice

Figure 4. — Survival analysis of all 94 GC patients. No correlation was detected between patient prognosis and the overexpression of FAS and HER2 when the data were analyzed separately. (A) Survival comparison by FAS in GC; P=0.4285; (B) survival comparison by mHER2 in GC; negative for a score of 0 and 1, positive for a score of 2 and 3; P=0.7094; (C) survival comparison by cHER2 in GC; weak for a score of <6, strong for a score of ≥6; P=0.5007. GC, gastric cancer; FAS, fatty acid synthase; mHER2, membranous human epidermal growth factor receptor 2; cHER2, cytoplasmic HER2; US, ultimate score.